Juliard J M, Masquet C, Baudouy Y, Gourgon R, Slama R
Service de Cardiologie, Hôpital Bichat, Paris.
C R Seances Soc Biol Fil. 1987;181(3):238-41.
Since September 1985, transluminal balloon catheter aortic valvuloplasty has been developed in France (Cribier and al.) and all around the world. Indications are still limited, in almost all catheterization laboratories, to elderly patients, with Monckeberg's disease, and with a very high operative risk. Immediately after aortic valvuloplasty, there is a moderate but a significant increase in valve area, without serious complications. Subjective improvement is often spectacular during few months after the valvuloplasty. In long-term evolution, there is sometimes a symptomatic restenosis which require a new valvuloplasty. So, if percutaneous valvuloplasty is efficacy in aortic stenosis in the elderly, long-term evaluation of this new technique is necessary.
自1985年9月起，经腔球囊导管主动脉瓣成形术已在法国（克里比埃等人）及世界各地得到发展。在几乎所有的心导管实验室中，其适应症仍局限于患有门克贝格氏病且手术风险极高的老年患者。主动脉瓣成形术后，瓣膜面积会有适度但显著的增加，且无严重并发症。瓣膜成形术后的几个月内，主观改善通常十分显著。在长期发展过程中，有时会出现有症状的再狭窄，这需要再次进行瓣膜成形术。所以，如果经皮瓣膜成形术对老年主动脉瓣狭窄有效，那么对这项新技术进行长期评估是必要的。
